Search Results - "Ebbo, Mikael"
-
1
Evidence of innate lymphoid cell redundancy in humans
Published in Nature immunology (01-11-2016)“…The importance of human innate lymphoid cells to normal human physiology is unclear. Vivier and colleagues find that immunodeficient patients ‘rescued’ with…”
Get full text
Journal Article -
2
Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study
Published in Blood (24-12-2020)“…Management of immune thrombocytopenia (ITP) during pregnancy can be challenging because treatment choices are limited. Thrombopoietin receptor agonists…”
Get full text
Journal Article -
3
An International Multispecialty Validation Study of the IgG4‐Related Disease Responder Index
Published in Arthritis care & research (2010) (01-11-2018)“…Objective IgG4‐related disease (IgG4‐RD) can cause fibroinflammatory lesions in nearly any organ, leading to organ dysfunction and failure. The IgG4‐RD…”
Get full text
Journal Article -
4
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome
Published in Autoimmunity reviews (01-10-2017)“…Atypical manifestations have been described in patients with ANCA-associated vasculitides (AAV), such as pachymeningitis, orbital mass or chronic periaortitis…”
Get full text
Journal Article -
5
The temporary use of thrombopoietin‐receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
Published in British journal of haematology (01-06-2014)“…Summary Thrombopoietin‐receptor agonists (Tpo‐RAs) are highly effective in immune thrombocytopenia (ITP). Recently, cases of durable remission after Tpo‐RA…”
Get full text
Journal Article -
6
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
Published in Blood (20-11-2014)“…We conducted a prospective multicenter registry of 248 adult patients with immune thrombocytopenia (ITP) treated with rituximab to assess safety. We also…”
Get full text
Journal Article -
7
A randomized and double‐blind controlled trial evaluating the safety and efficacy of rituximab for warm auto‐immune hemolytic anemia in adults (the RAIHA study)
Published in American journal of hematology (01-01-2017)“…This Phase 3 multicentre randomized double‐blind and placebo‐controlled trial aimed to compare the efficacy and safety of rituximab (RTX) to placebo for…”
Get full text
Journal Article -
8
Usefulness of 2‐[18F]‐fluoro‐2‐deoxy‐d‐glucose–Positron Emission Tomography/Computed Tomography for Staging and Evaluation of Treatment Response in IgG4‐Related Disease: A Retrospective Multicenter Study
Published in Arthritis care & research (2010) (01-01-2014)“…Objective To evaluate the usefulness of 2‐[18F]‐fluoro‐2‐deoxy‐d‐glucose–positron emission tomography/computed tomography (FDG‐PET/CT) in IgG4‐related disease…”
Get full text
Journal Article -
9
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Published in The Journal of clinical investigation (01-01-2013)“…Primary immune thrombocytopenia (ITP) is a disorder caused by autoantibody-mediated platelet destruction and decreased platelet production. Rituximab, a B…”
Get full text
Journal Article -
10
Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)
Published in Arthritis research & therapy (03-03-2021)“…Lupus animal model has shown that arsenic trioxide (ATO), a treatment of acute promyelocytic leukaemia, could be effective in SLE. This is the first clinical…”
Get full text
Journal Article -
11
Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients
Published in Journal of rheumatology (01-01-2017)“…Cardiac involvement during systemic lupus erythematosus (SLE) may include the pericardium, myocardium, valvular tissue, and coronary arteries. The aim of this…”
Get full text
Journal Article -
12
Development of an algorithm for IgG4-related disease management
Published in Autoimmunity reviews (01-03-2023)“…IgG4-related disease (IgG4-RD) is a rare fibro-inflammatory condition affecting multiple organs lacking standardized management. In this article, we review the…”
Get full text
Journal Article -
13
Life-threatening autoimmune warm hemolytic anemia following treatment for multiple sclerosis with alemtuzumab
Published in Multiple sclerosis (01-05-2018)“…Background: Alemtuzumab is a humanized monoclonal antibody directed at CD52 approved as a disease-modifying therapy for relapsing forms of multiple sclerosis…”
Get full text
Journal Article -
14
Thoracic involvement and imaging patterns in IgG4-related disease
Published in European respiratory review (31-12-2021)“…Immunoglobulin G4-related disease (IgG4-RD) is a rare orphan disease. Lung, pleura, pericardium, mediastinum, aorta and lymph node involvement has been…”
Get full text
Journal Article -
15
Implication of allergy and atopy in IgG4-related disease
Published in The World Allergy Organization journal (01-04-2023)“…Immunoglobulin G4-related disease (IgG4-RD) is a chronic multi-organic immune fibrosing disease. It affects preferentially men around middle age and almost any…”
Get full text
Journal Article -
16
Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study
Published in Platelets (Edinburgh) (31-12-2023)“…The emergence of rituximab biosimilars offers the prospect of significant savings to the healthcare system. However, these drugs have never been evaluated for…”
Get full text
Journal Article -
17
Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis
Published in European radiology (01-12-2019)“…Objective To study a muscle-to-muscle standardised uptake value (SUV) ratio with FDG-PET/CT (FDG-PET) as a marker for the detection of disease activity in…”
Get full text
Journal Article -
18
Pulmonary IgG4‐related disease with favourable response to rituximab: A case report
Published in Respirology case reports (01-12-2022)“…Pulmonary involvement of IgG4‐associated disease is a rare condition with no codified treatment apart from steroid administration. We report here the case of a…”
Get full text
Journal Article -
19
Late-Onset Progressive Multifocal Leukoencephalopathy (PML) and Lymphoma in a 65-Year-Old Patient with XIAP Deficiency
Published in Journal of clinical immunology (01-11-2021)Get full text
Journal Article -
20
Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature review
Published in Frontiers in immunology (23-04-2024)“…Eosinophils have widespread procoagulant effects. In daily practice, eosinophil-related cardiovascular toxicity consists of endomyocardial damage, eosinophilic…”
Get full text
Journal Article